These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22892944)

  • 1. [Relapse prevention in alcohol dependence: acamprosate and naltrexone as a combined pharmacological strategy].
    Gahr M; Kölle MA; Schönfeldt-Lecuona C
    Nervenarzt; 2013 May; 84(5):584-9. PubMed ID: 22892944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.
    Kiefer F; Jahn H; Tarnaske T; Helwig H; Briken P; Holzbach R; Kämpf P; Stracke R; Baehr M; Naber D; Wiedemann K
    Arch Gen Psychiatry; 2003 Jan; 60(1):92-9. PubMed ID: 12511176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.
    Littleton J; Zieglgänsberger W
    Am J Addict; 2003; 12(s1):s3-s11. PubMed ID: 14972776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
    Soyka M; Chick J
    Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.
    Gueorguieva R; Wu R; Donovan D; Rounsaville BJ; Couper D; Krystal JH; O'Malley SS
    Alcohol Clin Exp Res; 2011 Mar; 35(3):523-31. PubMed ID: 21143249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for combining acamprosate and naltrexone for treating alcohol dependence.
    Mason BJ
    J Stud Alcohol Suppl; 2005 Jul; (15):148-56; discussion 140. PubMed ID: 16223066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
    Bouza C; Angeles M; Muñoz A; Amate JM
    Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy: what does acamprosate and naltrexone combination tell us?
    Kiefer F; Wiedemann K
    Alcohol Alcohol; 2004; 39(6):542-7. PubMed ID: 15456690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.
    Fucito LM; Park A; Gulliver SB; Mattson ME; Gueorguieva RV; O'Malley SS
    Biol Psychiatry; 2012 Nov; 72(10):832-8. PubMed ID: 22541040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pharmacologic treatment of the alcohol dependence].
    Castro LA; Baltieri DA
    Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of healthcare utilization among patients treated with alcoholism medications.
    Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
    Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.
    Mason BJ; Goodman AM; Dixon RM; Hameed MH; Hulot T; Wesnes K; Hunter JA; Boyeson MG
    Neuropsychopharmacology; 2002 Oct; 27(4):596-606. PubMed ID: 12377396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.
    Jung YC; Namkoong K
    Yonsei Med J; 2006 Apr; 47(2):167-78. PubMed ID: 16642544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.